Millennium Management
OACC

Millennium Management’s Oaktree Acquisition Corp III Life Sciences OACC Stock Holding History

Millennium Management’s Portfolio OACC Stock Details OACC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.85M Sell
175,000
-98,914
-36% -$1.05M ﹤0.01% 3941
2025
Q4 		$2.9M Hold
273,914
– – ﹤0.01% 3603
2025
Q3 		$2.88M Hold
273,914
– – ﹤0.01% 3710
2025
Q2 		$2.86M Sell
273,914
-200,000
-42% -$2.07M ﹤0.01% 3554
2025
Q1 		$4.85M Buy
+473,914
New +$4.76M ﹤0.01% 2896

Other funds holding OACC

AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
DAM
Decagon Asset Management London, United Kingdom $386M AUM 45.42% 1-Year Est. Return
FBCM
Fort Baker Capital Management Larkspur, California $1.27B AUM 25.46% 1-Year Est. Return
ECP
Empyrean Capital Partners Los Angeles, California $3.07B AUM 34.24% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
BGIM
Boussard & Gavaudan Investment Management London, United Kingdom $1.06B AUM 4.58% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
MCM
Moore Capital Management New York $4.92B AUM 35.41% 1-Year Est. Return

Millennium Management's OACC Position: Q1 2026 in Review

Millennium Management reduced its Oaktree Acquisition Corp III Life Sciences (OACC) stake by 36% in Q1 2026, selling an estimated $1.05M and leaving 175,000 shares worth $1.85M. The position accounts for ﹤0.01% of the portfolio, ranked #3941.

Millennium Management first reported a position in OACC in Q1 2025 and has held it in 5 quarters since. The position peaked at $4.85M in Q1 2025. 51 funds tracked by Wall St. Rank hold OACC as of Q1 2026.

  • Millennium Management held 175,000 shares of Oaktree Acquisition Corp III Life Sciences worth $1.85M as of Q1 2026.
  • Millennium Management sold 98,914 Oaktree Acquisition Corp III Life Sciences shares in Q1 2026, an estimated $1.05M.
  • Oaktree Acquisition Corp III Life Sciences made up ﹤0.01% of Millennium Management's portfolio in Q1 2026, its #3941 holding.
  • Millennium Management first reported a position in Oaktree Acquisition Corp III Life Sciences in Q1 2025 and has held it in 5 quarters since.
  • Millennium Management's Oaktree Acquisition Corp III Life Sciences position peaked at $4.85M in Q1 2025.
  • 51 funds tracked by Wall St. Rank held Oaktree Acquisition Corp III Life Sciences as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.